Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.15 USD | +1.72% | -0.48% | -11.70% |
May. 21 | Oppenheimer Adjusts Savara Price Target to $11 From $9.50, Maintains Outperform Rating | MT |
May. 09 | Savara Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
564M | - | - | - | - | - | |
118B | ||||||
106B | ||||||
23.4B | - | |||||
22.1B | - | |||||
18.34B |
- Stock Market
- Equities
- SVRA Stock
- Charts Savara Inc.
- Sector Chart